Platelet count is a marker of outcome in community-acquired pneumonia

D. Martínez, F. Sanz, E. Fernández, A. Cervera, M. L. Briones, M. C. Aguar, E. Chiner, J. N. Sancho, C. Senent, L. Gil, L. Novella, S. Herrera, C. Miralles, J. Berraondo, J. Blanquer, CAPAVANT Study Group (Valencia, Alacant, Spain)

Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Session: Bacterial, fungal and mycobacterial infections
Session type: Thematic Poster Session
Number: 4377
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Martínez, F. Sanz, E. Fernández, A. Cervera, M. L. Briones, M. C. Aguar, E. Chiner, J. N. Sancho, C. Senent, L. Gil, L. Novella, S. Herrera, C. Miralles, J. Berraondo, J. Blanquer, CAPAVANT Study Group (Valencia, Alacant, Spain). Platelet count is a marker of outcome in community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 4377

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Community-acquired pneumonia in HIV-infected patients: The relevance of CD4+ cell count
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014


The prevalence of cardiac diseases in patients with community-acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Epidemiological features of hospital-acquired pneumonia in a neurosurgical center in Ukraine
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013


Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Prior antibiotics and outcomes in patients hospitalized with pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Bacteremia in non-HIV community acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


YKL-40 and CCL18 predict mortality in patients hospitalised with community-acquired pneumonia; an observational analysis
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Empiric penicillin monotherapy of CAP is not associated with increased mortality; experiences from the retrospective CAP-North cohort
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Clinical characteristics of extremely elderly patients with community-acquired and healthcare-associated pneumonia in Japan
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013

Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013